Sanofi Stock News

The shots could be geared towards children, new variants or boosters.

French drug maker Sanofi S.A. has agreed to make Moderna Inc.'s COVID-19 vaccine at its site in Ridgefield, New Jersey, and will fill and finish up to 200 million doses starting in September.

Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc's (NASDAQ: AZN) monoclonal antibody (mAb) nirsevimab has reached its primary endpoint in a Phase 3 trial, demonstrating protection against respirator

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). e are only interested in those targets that are attractively valued in historical comparison.

Boston-area biotech Replimune Group Inc. (NASDAQ:REPL) just boosted its executive lineup with a heavy hitter, and the market seems to like the addition.

SYDNEY, April 19, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce that it has entered into a worldwide ex

All down 45% or more from their 52-week highs, should you consider cutting your losses?

BOE: Global Exposure At A Discount

Sanofi's (SNY) acquisition of Tidal Therapeutics for $160 million is set to aid innovative mRNA-based research platform with applications in oncology, immunology and other diseases.

U.S.-listed shares of Sanofi gained 0.7% in premarket trading on Wednesday after the company said it has formed a nonprofit business unit that will provide 30 essential medicines to 40 lower-income co

PARIS, April 7, 2021 /PRNewswire/ -- In an open letter, Sanofi Chief Executive Officer Paul Hudson today outlined several key projects that the company will implement to increase the impact of its Co

There are five billion reasons these companies hope it's not.

They are yielding twice the monthly spot rate on 20-year high-quality market corporate bonds

Revolution Medicines' leading compound is shaping up to be a platform in a pill.

Sanofi's (SNY) Sarclisa gets FDA approval to treat multiple myeloma patients who have received one to three prior lines of therapy in combination with Kyprolis and dexamethasone.